These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2143400)

  • 1. Management of breast and prostate cancer: how does quality of life enter the equation?
    Tannock IF
    Oncology (Williston Park); 1990 May; 4(5):149-56; discussion 171. PubMed ID: 2143400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life as a treatment endpoint in metastatic breast cancer.
    Osoba D
    Can J Oncol; 1995 Dec; 5 Suppl 1():47-53. PubMed ID: 8853525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in advanced prostate cancer.
    Fosså SD
    Semin Oncol; 1996 Dec; 23(6 Suppl 14):32-4. PubMed ID: 8996583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information satisfaction in breast and prostate cancer patients: implications for quality of life.
    Davies NJ; Kinman G; Thomas RJ; Bailey T
    Psychooncology; 2008 Oct; 17(10):1048-52. PubMed ID: 18203242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
    Pummer K; Lehnert M; Stettner H; Hubmer G
    Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients.
    Carlson LE; Speca M; Faris P; Patel KD
    Brain Behav Immun; 2007 Nov; 21(8):1038-49. PubMed ID: 17521871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy.
    Trask PC
    Health Qual Life Outcomes; 2004 Jul; 2():37. PubMed ID: 15272941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures.
    Knight SJ; Chmiel JS; Kuzel T; Sharp L; Albers M; Fine R; Moran EM; Nadler RB; Sharifi R; Bennett CL
    J Urol; 1998 Nov; 160(5):1765-9. PubMed ID: 9783948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
    Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
    Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
    Rosenfeld B; Roth AJ; Gandhi S; Penson D
    Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First line therapy in the treatment of metastatic prostate cancer].
    Sakai H; Kanetake H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life after therapy for localized prostate cancer.
    Penson DF
    Cancer J; 2007; 13(5):318-26. PubMed ID: 17921731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life among patients with advanced prostate cancer: a survey using functional assessment of cancer therapy-prostate in China].
    Zhang K; Gong K; Zhou LQ; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):665-8. PubMed ID: 18642765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.
    Karamouzis MV; Ioannidis G; Rigatos G
    Eur J Cancer Care (Engl); 2007 Sep; 16(5):433-8. PubMed ID: 17760930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
    Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
    Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life in men with prostate cancer.
    Penson DF; Litwin MS; Aaronson NK
    J Urol; 2003 May; 169(5):1653-61. PubMed ID: 12686803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life for men with prostate cancer.
    Katz A
    Cancer Nurs; 2007; 30(4):302-8. PubMed ID: 17666980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.